ArticleCell death discovery2022

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway.

Yueda Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.